Linshom

Executive Summary

Linshom Medical is a digital health company specializing in respiratory monitoring with its FDA-cleared wearable device that delivers continuous, operating room-quality respiratory data at the patient bedside. The company's technology addresses a critical gap in patient monitoring, aiming to reduce morbidity, mortality, and healthcare costs associated with unrecognized respiratory decline. Founded in 2015 and based in San Francisco, Linshom is positioned in the respiratory and digital health sectors, targeting hospital and post-acute care settings. The device's non-invasive, continuous monitoring capabilities offer a potential advantage over intermittent spot checks, enabling earlier intervention and improved patient outcomes. While the company has secured FDA clearance, its commercial traction, scalability, and competitive differentiation remain key factors to watch. Linshom operates in a market with established players but could capture share by leveraging its unique continuous monitoring approach. The company's stage and total funding are not disclosed, suggesting it may be early in its commercialization journey or operating with limited public information.

Upcoming Catalysts (preview)

• Q4 2026Commercial Partnership with Major Hospital Network70% success
• Q2 2027Publication of Clinical Outcomes Data from Multi-Center Study60% success